<?xml version='1.0' encoding='UTF-8'?>
<uniprot>
<entry dataset="Swiss-Prot" created="1998-12-15" modified="2015-01-07" version="165">
<accession>O60674</accession>
<accession>O14636</accession>
<accession>O75297</accession>
<name>JAK2_HUMAN</name>
<protein>
<recommendedName>
<fullName>Tyrosine-protein kinase JAK2</fullName>
<ecNumber>2.7.10.2</ecNumber>
</recommendedName>
<alternativeName>
<fullName>Janus kinase 2</fullName>
<shortName>JAK-2</shortName>
</alternativeName>
</protein>
<gene>
<name type="primary">JAK2</name>
</gene>
<organism>
<name type="scientific">Homo sapiens</name>
<name type="common">Human</name>
<dbReference type="NCBI Taxonomy" id="9606"/>
<lineage>
<taxon>Eukaryota</taxon>
<taxon>Metazoa</taxon>
<taxon>Chordata</taxon>
<taxon>Craniata</taxon>
<taxon>Vertebrata</taxon>
<taxon>Euteleostomi</taxon>
<taxon>Mammalia</taxon>
<taxon>Eutheria</taxon>
<taxon>Euarchontoglires</taxon>
<taxon>Primates</taxon>
<taxon>Haplorrhini</taxon>
<taxon>Catarrhini</taxon>
<taxon>Hominidae</taxon>
<taxon>Homo</taxon>
</lineage>
</organism>
<reference key="1">
<citation type="journal article" date="1998" name="Biochem. Biophys. Res. Commun." volume="246" first="627" last="633">
<title>Cloning and characterization of human Jak-2 kinase: high mRNA expression in immune cells and muscle tissue.</title>
<authorList>
<person name="Saltzman A."/>
<person name="Stone M."/>
<person name="Franks C."/>
<person name="Searfoss G."/>
<person name="Munro R."/>
<person name="Jaye M."/>
<person name="Ivashchenko Y."/>
</authorList>
<dbReference type="PubMed" id="9618263"/>
<dbReference type="DOI" id="10.1006/bbrc.1998.8685"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA]</scope>
</reference>
<reference key="2">
<citation type="journal article" date="1998" name="Blood" volume="91" first="844" last="851">
<title>Cloning and characterization of the human homolog of mouse Jak2.</title>
<authorList>
<person name="Dalal I."/>
<person name="Arpaia E."/>
<person name="Dadi H."/>
<person name="Kulkarni S."/>
<person name="Squire J."/>
<person name="Roifman C.M."/>
</authorList>
<dbReference type="PubMed" id="9446644"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA]</scope>
</reference>
<reference key="3">
<citation type="journal article" date="1997" name="Blood" volume="90" first="2535" last="2540">
<title>Fusion of TEL, the ETS-variant gene 6 (ETV6), to the receptor-associated kinase JAK2 as a result of t(9;12) in a lymphoid and t(9;15;12) in a myeloid leukemia.</title>
<authorList>
<person name="Peeters P."/>
<person name="Raynaud S.D."/>
<person name="Cools J."/>
<person name="Wlodarska I."/>
<person name="Grosgeorge J."/>
<person name="Philip P."/>
<person name="Monpoux F."/>
<person name="Van Rompaey L."/>
<person name="Baens M."/>
<person name="Van Den Berghe H."/>
<person name="Marynen P."/>
</authorList>
<dbReference type="PubMed" id="9326218"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA]</scope>
<scope>CHROMOSOMAL TRANSLOCATION WITH ETV6</scope>
</reference>
<reference key="4">
<citation type="journal article" date="2004" name="Nature" volume="429" first="369" last="374">
<title>DNA sequence and analysis of human chromosome 9.</title>
<authorList>
<person name="Humphray S.J."/>
<person name="Oliver K."/>
<person name="Hunt A.R."/>
<person name="Plumb R.W."/>
<person name="Loveland J.E."/>
<person name="Howe K.L."/>
<person name="Andrews T.D."/>
<person name="Searle S."/>
<person name="Hunt S.E."/>
<person name="Scott C.E."/>
<person name="Jones M.C."/>
<person name="Ainscough R."/>
<person name="Almeida J.P."/>
<person name="Ambrose K.D."/>
<person name="Ashwell R.I.S."/>
<person name="Babbage A.K."/>
<person name="Babbage S."/>
<person name="Bagguley C.L."/>
<person name="Bailey J."/>
<person name="Banerjee R."/>
<person name="Barker D.J."/>
<person name="Barlow K.F."/>
<person name="Bates K."/>
<person name="Beasley H."/>
<person name="Beasley O."/>
<person name="Bird C.P."/>
<person name="Bray-Allen S."/>
<person name="Brown A.J."/>
<person name="Brown J.Y."/>
<person name="Burford D."/>
<person name="Burrill W."/>
<person name="Burton J."/>
<person name="Carder C."/>
<person name="Carter N.P."/>
<person name="Chapman J.C."/>
<person name="Chen Y."/>
<person name="Clarke G."/>
<person name="Clark S.Y."/>
<person name="Clee C.M."/>
<person name="Clegg S."/>
<person name="Collier R.E."/>
<person name="Corby N."/>
<person name="Crosier M."/>
<person name="Cummings A.T."/>
<person name="Davies J."/>
<person name="Dhami P."/>
<person name="Dunn M."/>
<person name="Dutta I."/>
<person name="Dyer L.W."/>
<person name="Earthrowl M.E."/>
<person name="Faulkner L."/>
<person name="Fleming C.J."/>
<person name="Frankish A."/>
<person name="Frankland J.A."/>
<person name="French L."/>
<person name="Fricker D.G."/>
<person name="Garner P."/>
<person name="Garnett J."/>
<person name="Ghori J."/>
<person name="Gilbert J.G.R."/>
<person name="Glison C."/>
<person name="Grafham D.V."/>
<person name="Gribble S."/>
<person name="Griffiths C."/>
<person name="Griffiths-Jones S."/>
<person name="Grocock R."/>
<person name="Guy J."/>
<person name="Hall R.E."/>
<person name="Hammond S."/>
<person name="Harley J.L."/>
<person name="Harrison E.S.I."/>
<person name="Hart E.A."/>
<person name="Heath P.D."/>
<person name="Henderson C.D."/>
<person name="Hopkins B.L."/>
<person name="Howard P.J."/>
<person name="Howden P.J."/>
<person name="Huckle E."/>
<person name="Johnson C."/>
<person name="Johnson D."/>
<person name="Joy A.A."/>
<person name="Kay M."/>
<person name="Keenan S."/>
<person name="Kershaw J.K."/>
<person name="Kimberley A.M."/>
<person name="King A."/>
<person name="Knights A."/>
<person name="Laird G.K."/>
<person name="Langford C."/>
<person name="Lawlor S."/>
<person name="Leongamornlert D.A."/>
<person name="Leversha M."/>
<person name="Lloyd C."/>
<person name="Lloyd D.M."/>
<person name="Lovell J."/>
<person name="Martin S."/>
<person name="Mashreghi-Mohammadi M."/>
<person name="Matthews L."/>
<person name="McLaren S."/>
<person name="McLay K.E."/>
<person name="McMurray A."/>
<person name="Milne S."/>
<person name="Nickerson T."/>
<person name="Nisbett J."/>
<person name="Nordsiek G."/>
<person name="Pearce A.V."/>
<person name="Peck A.I."/>
<person name="Porter K.M."/>
<person name="Pandian R."/>
<person name="Pelan S."/>
<person name="Phillimore B."/>
<person name="Povey S."/>
<person name="Ramsey Y."/>
<person name="Rand V."/>
<person name="Scharfe M."/>
<person name="Sehra H.K."/>
<person name="Shownkeen R."/>
<person name="Sims S.K."/>
<person name="Skuce C.D."/>
<person name="Smith M."/>
<person name="Steward C.A."/>
<person name="Swarbreck D."/>
<person name="Sycamore N."/>
<person name="Tester J."/>
<person name="Thorpe A."/>
<person name="Tracey A."/>
<person name="Tromans A."/>
<person name="Thomas D.W."/>
<person name="Wall M."/>
<person name="Wallis J.M."/>
<person name="West A.P."/>
<person name="Whitehead S.L."/>
<person name="Willey D.L."/>
<person name="Williams S.A."/>
<person name="Wilming L."/>
<person name="Wray P.W."/>
<person name="Young L."/>
<person name="Ashurst J.L."/>
<person name="Coulson A."/>
<person name="Blocker H."/>
<person name="Durbin R.M."/>
<person name="Sulston J.E."/>
<person name="Hubbard T."/>
<person name="Jackson M.J."/>
<person name="Bentley D.R."/>
<person name="Beck S."/>
<person name="Rogers J."/>
<person name="Dunham I."/>
</authorList>
<dbReference type="PubMed" id="15164053"/>
<dbReference type="DOI" id="10.1038/nature02465"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]</scope>
</reference>
<reference key="5">
<citation type="journal article" date="1999" name="J. Biol. Chem." volume="274" first="31531" last="31542">
<title>The human homologue of the yeast proteins Skb1 and Hsl7p interacts with Jak kinases and contains protein methyltransferase activity.</title>
<authorList>
<person name="Pollack B.P."/>
<person name="Kotenko S.V."/>
<person name="He W."/>
<person name="Izotova L.S."/>
<person name="Barnoski B.L."/>
<person name="Pestka S."/>
</authorList>
<dbReference type="PubMed" id="10531356"/>
<dbReference type="DOI" id="10.1074/jbc.274.44.31531"/>
</citation>
<scope>INTERACTION WITH SKB1</scope>
</reference>
<reference key="6">
<citation type="journal article" date="2000" name="FEBS Lett." volume="477" first="55" last="61">
<title>STAM2, a new member of the STAM family, binding to the Janus kinases.</title>
<authorList>
<person name="Endo K."/>
<person name="Takeshita T."/>
<person name="Kasai H."/>
<person name="Sasaki Y."/>
<person name="Tanaka N."/>
<person name="Asao H."/>
<person name="Kikuchi K."/>
<person name="Yamada M."/>
<person name="Chenb M."/>
<person name="O'Shea J.J."/>
<person name="Sugamura K."/>
</authorList>
<dbReference type="PubMed" id="10899310"/>
<dbReference type="DOI" id="10.1016/S0014-5793(00)01760-9"/>
</citation>
<scope>INTERACTION WITH STAM2</scope>
<source>
<tissue>Fetal brain</tissue>
</source>
</reference>
<reference key="7">
<citation type="journal article" date="2002" name="J. Immunol." volume="168" first="5699" last="5708">
<title>A receptor for the heterodimeric cytokine IL-23 is composed of IL-12Rbeta1 and a novel cytokine receptor subunit, IL-23R.</title>
<authorList>
<person name="Parham C."/>
<person name="Chirica M."/>
<person name="Timans J."/>
<person name="Vaisberg E."/>
<person name="Travis M."/>
<person name="Cheung J."/>
<person name="Pflanz S."/>
<person name="Zhang R."/>
<person name="Singh K.P."/>
<person name="Vega F."/>
<person name="To W."/>
<person name="Wagner J."/>
<person name="O'Farrell A.-M."/>
<person name="McClanahan T.K."/>
<person name="Zurawski S."/>
<person name="Hannum C."/>
<person name="Gorman D."/>
<person name="Rennick D.M."/>
<person name="Kastelein R.A."/>
<person name="de Waal Malefyt R."/>
<person name="Moore K.W."/>
</authorList>
<dbReference type="PubMed" id="12023369"/>
<dbReference type="DOI" id="10.4049/jimmunol.168.11.5699"/>
</citation>
<scope>FUNCTION</scope>
<scope>INTERACTION WITH IL23R</scope>
</reference>
<reference key="8">
<citation type="journal article" date="2005" name="Cancer Res." volume="65" first="2662" last="2667">
<title>The t(8;9)(p22;p24) is a recurrent abnormality in chronic and acute leukemia that fuses PCM1 to JAK2.</title>
<authorList>
<person name="Reiter A."/>
<person name="Walz C."/>
<person name="Watmore A."/>
<person name="Schoch C."/>
<person name="Blau I."/>
<person name="Schlegelberger B."/>
<person name="Berger U."/>
<person name="Telford N."/>
<person name="Aruliah S."/>
<person name="Yin J.A."/>
<person name="Vanstraelen D."/>
<person name="Barker H.F."/>
<person name="Taylor P.C."/>
<person name="O'Driscoll A."/>
<person name="Benedetti F."/>
<person name="Rudolph C."/>
<person name="Kolb H.-J."/>
<person name="Hochhaus A."/>
<person name="Hehlmann R."/>
<person name="Chase A."/>
<person name="Cross N.C.P."/>
</authorList>
<dbReference type="PubMed" id="15805263"/>
<dbReference type="DOI" id="10.1158/0008-5472.CAN-04-4263"/>
</citation>
<scope>CHROMOSOMAL TRANSLOCATION WITH PCM1</scope>
</reference>
<reference key="9">
<citation type="journal article" date="2005" name="Leukemia" volume="19" first="1692" last="1696">
<title>PCM1-JAK2 fusion in myeloproliferative disorders and acute erythroid leukemia with t(8;9) translocation.</title>
<authorList>
<person name="Murati A."/>
<person name="Gelsi-Boyer V."/>
<person name="Adelaide J."/>
<person name="Perot C."/>
<person name="Talmant P."/>
<person name="Giraudier S."/>
<person name="Lode L."/>
<person name="Letessier A."/>
<person name="Delaval B."/>
<person name="Brunel V."/>
<person name="Imbert M."/>
<person name="Garand R."/>
<person name="Xerri L."/>
<person name="Birnbaum D."/>
<person name="Mozziconacci M.-J."/>
<person name="Chaffanet M."/>
</authorList>
<dbReference type="PubMed" id="16034466"/>
<dbReference type="DOI" id="10.1038/sj.leu.2403879"/>
</citation>
<scope>CHROMOSOMAL TRANSLOCATION WITH PCM1</scope>
</reference>
<reference key="10">
<citation type="journal article" date="2005" name="Oncogene" volume="24" first="7248" last="7252">
<title>The t(8;9)(p22;p24) translocation in atypical chronic myeloid leukaemia yields a new PCM1-JAK2 fusion gene.</title>
<authorList>
<person name="Bousquet M."/>
<person name="Quelen C."/>
<person name="De Mas V."/>
<person name="Duchayne E."/>
<person name="Roquefeuil B."/>
<person name="Delsol G."/>
<person name="Laurent G."/>
<person name="Dastugue N."/>
<person name="Brousset P."/>
</authorList>
<dbReference type="PubMed" id="16091753"/>
<dbReference type="DOI" id="10.1038/sj.onc.1208850"/>
</citation>
<scope>CHROMOSOMAL TRANSLOCATION WITH PCM1</scope>
</reference>
<reference key="11">
<citation type="journal article" date="2006" name="Haematologica" volume="91" first="817" last="820">
<title>A combination of cytomorphology, cytogenetic analysis, fluorescence in situ hybridization and reverse transcriptase polymerase chain reaction for establishing clonality in cases of persisting hypereosinophilia.</title>
<authorList>
<person name="Bacher U."/>
<person name="Reiter A."/>
<person name="Haferlach T."/>
<person name="Mueller L."/>
<person name="Schnittger S."/>
<person name="Kern W."/>
<person name="Schoch C."/>
</authorList>
<dbReference type="PubMed" id="16769584"/>
</citation>
<scope>CHROMOSOMAL TRANSLOCATION WITH PCM1</scope>
</reference>
<reference key="12">
<citation type="journal article" date="2006" name="Leukemia" volume="20" first="536" last="537">
<title>A t(8;9) translocation with PCM1-JAK2 fusion in a patient with T-cell lymphoma.</title>
<authorList>
<person name="Adelaide J."/>
<person name="Perot C."/>
<person name="Gelsi-Boyer V."/>
<person name="Pautas C."/>
<person name="Murati A."/>
<person name="Copie-Bergman C."/>
<person name="Imbert M."/>
<person name="Chaffanet M."/>
<person name="Birnbaum D."/>
<person name="Mozziconacci M.-J."/>
</authorList>
<dbReference type="PubMed" id="16424865"/>
<dbReference type="DOI" id="10.1038/sj.leu.2404104"/>
</citation>
<scope>TISSUE SPECIFICITY</scope>
<scope>CHROMOSOMAL TRANSLOCATION WITH PCM1</scope>
</reference>
<reference key="13">
<citation type="journal article" date="2009" name="Nature" volume="461" first="819" last="822">
<title>JAK2 phosphorylates histone H3Y41 and excludes HP1alpha from chromatin.</title>
<authorList>
<person name="Dawson M.A."/>
<person name="Bannister A.J."/>
<person name="Gottgens B."/>
<person name="Foster S.D."/>
<person name="Bartke T."/>
<person name="Green A.R."/>
<person name="Kouzarides T."/>
</authorList>
<dbReference type="PubMed" id="19783980"/>
<dbReference type="DOI" id="10.1038/nature08448"/>
</citation>
<scope>FUNCTION</scope>
<scope>SUBCELLULAR LOCATION</scope>
</reference>
<reference key="14">
<citation type="journal article" date="2010" name="Biochem. Biophys. Res. Commun." volume="403" first="30" last="35">
<title>Heme controls the regulation of protein tyrosine kinases Jak2 and Src.</title>
<authorList>
<person name="Yao X."/>
<person name="Balamurugan P."/>
<person name="Arvey A."/>
<person name="Leslie C."/>
<person name="Zhang L."/>
</authorList>
<dbReference type="PubMed" id="21036157"/>
<dbReference type="DOI" id="10.1016/j.bbrc.2010.10.101"/>
</citation>
<scope>ENZYME REGULATION</scope>
</reference>
<reference key="15">
<citation type="journal article" date="2010" name="Nat. Med." volume="16" first="183" last="190">
<title>The Rho exchange factor Arhgef1 mediates the effects of angiotensin II on vascular tone and blood pressure.</title>
<authorList>
<person name="Guilluy C."/>
<person name="Bregeon J."/>
<person name="Toumaniantz G."/>
<person name="Rolli-Derkinderen M."/>
<person name="Retailleau K."/>
<person name="Loufrani L."/>
<person name="Henrion D."/>
<person name="Scalbert E."/>
<person name="Bril A."/>
<person name="Torres R.M."/>
<person name="Offermanns S."/>
<person name="Pacaud P."/>
<person name="Loirand G."/>
</authorList>
<dbReference type="PubMed" id="20098430"/>
<dbReference type="DOI" id="10.1038/nm.2079"/>
</citation>
<scope>FUNCTION</scope>
</reference>
<reference key="16">
<citation type="journal article" date="2011" name="Oncogene" volume="30" first="3502" last="3512">
<title>Phosphorylation of p27Kip1 by JAK2 directly links cytokine receptor signaling to cell cycle control.</title>
<authorList>
<person name="Jakel H."/>
<person name="Weinl C."/>
<person name="Hengst L."/>
</authorList>
<dbReference type="PubMed" id="21423214"/>
<dbReference type="DOI" id="10.1038/onc.2011.68"/>
</citation>
<scope>FUNCTION IN PHOSPHORYLATION OF CDKN1B</scope>
</reference>
<reference key="17">
<citation type="journal article" date="2006" name="Cell Biochem. Biophys." volume="44" first="213" last="222">
<title>Jak2 tyrosine kinase: a mediator of both housekeeping and ligand-dependent gene expression?</title>
<authorList>
<person name="Wallace T.A."/>
<person name="Sayeski P.P."/>
</authorList>
<dbReference type="PubMed" id="16456223"/>
<dbReference type="DOI" id="10.1385/CBB:44:2:213"/>
</citation>
<scope>REVIEW ON FUNCTION</scope>
</reference>
<reference key="18">
<citation type="journal article" date="2009" name="Immunol. Rev." volume="228" first="273" last="287">
<title>Janus kinases in immune cell signaling.</title>
<authorList>
<person name="Ghoreschi K."/>
<person name="Laurence A."/>
<person name="O'Shea J.J."/>
</authorList>
<dbReference type="PubMed" id="19290934"/>
<dbReference type="DOI" id="10.1111/j.1600-065X.2008.00754.x"/>
</citation>
<scope>REVIEW ON FUNCTION</scope>
</reference>
<reference key="19">
<citation type="journal article" date="2006" name="Blood" volume="107" first="176" last="183">
<title>The structural basis of Janus kinase 2 inhibition by a potent and specific pan-Janus kinase inhibitor.</title>
<authorList>
<person name="Lucet I.S."/>
<person name="Fantino E."/>
<person name="Styles M."/>
<person name="Bamert R."/>
<person name="Patel O."/>
<person name="Broughton S.E."/>
<person name="Walter M."/>
<person name="Burns C.J."/>
<person name="Treutlein H."/>
<person name="Wilks A.F."/>
<person name="Rossjohn J."/>
</authorList>
<dbReference type="PubMed" id="16174768"/>
<dbReference type="DOI" id="10.1182/blood-2005-06-2413"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.0 ANGSTROMS) OF 840-1132 IN COMPLEX WITH SYNTHETIC INHIBITOR</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY</scope>
<scope>PHOSPHORYLATION AT TYR-1007 AND TYR-1008</scope>
</reference>
<reference key="20">
<citation type="journal article" date="2005" name="Lancet" volume="365" first="1054" last="1061">
<title>Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders.</title>
<authorList>
<consortium name="The cancer genome project"/>
<person name="Baxter E.J."/>
<person name="Scott L.M."/>
<person name="Campbell P.J."/>
<person name="East C."/>
<person name="Fourouclas N."/>
<person name="Swanton S."/>
<person name="Vassiliou G.S."/>
<person name="Bench A.J."/>
<person name="Boyd E.M."/>
<person name="Curtin N."/>
<person name="Scott M.A."/>
<person name="Erber W.N."/>
<person name="Green A.R."/>
</authorList>
<dbReference type="PubMed" id="15781101"/>
<dbReference type="DOI" id="10.1016/S0140-6736(05)71142-9"/>
</citation>
<scope>VARIANT PV PHE-617</scope>
</reference>
<reference key="21">
<citation type="journal article" date="2005" name="Lancet" volume="366" first="122" last="122">
<authorList>
<consortium name="The cancer genome project"/>
<person name="Baxter E.J."/>
<person name="Scott L.M."/>
<person name="Campbell P.J."/>
<person name="East C."/>
<person name="Fourouclas N."/>
<person name="Swanton S."/>
<person name="Vassiliou G.S."/>
<person name="Bench A.J."/>
<person name="Boyd E.M."/>
<person name="Curtin N."/>
<person name="Scott M.A."/>
<person name="Erber W.N."/>
<person name="Green A.R."/>
</authorList>
</citation>
<scope>ERRATUM</scope>
</reference>
<reference key="22">
<citation type="journal article" date="2005" name="Lancet" volume="366" first="1945" last="1953">
<title>Definition of subtypes of essential thrombocythaemia and relation to polycythaemia vera based on JAK2 V617F mutation status: a prospective study.</title>
<authorList>
<consortium name="The United Kingdom myeloproliferative disorders study group"/>
<consortium name="The medical research council adult leukaemia working party"/>
<consortium name="The Australasian leukaemia and lymphoma group"/>
<person name="Campbell P.J."/>
<person name="Scott L.M."/>
<person name="Buck G."/>
<person name="Wheatley K."/>
<person name="East C.L."/>
<person name="Marsden J.T."/>
<person name="Duffy A."/>
<person name="Boyd E.M."/>
<person name="Bench A.J."/>
<person name="Scott M.A."/>
<person name="Vassiliou G.S."/>
<person name="Milligan D.W."/>
<person name="Smith S.R."/>
<person name="Erber W.N."/>
<person name="Bareford D."/>
<person name="Wilkins B.S."/>
<person name="Reilly J.T."/>
<person name="Harrison C.N."/>
<person name="Green A.R."/>
</authorList>
<dbReference type="PubMed" id="16325696"/>
<dbReference type="DOI" id="10.1016/S0140-6736(05)67785-9"/>
</citation>
<scope>VARIANT THCYT3 PHE-617</scope>
</reference>
<reference key="23">
<citation type="journal article" date="2005" name="Nature" volume="434" first="1144" last="1148">
<title>A unique clonal JAK2 mutation leading to constitutive signalling causes polycythaemia vera.</title>
<authorList>
<person name="James C."/>
<person name="Ugo V."/>
<person name="Le Couedic J.-P."/>
<person name="Staerk J."/>
<person name="Delhommeau F."/>
<person name="Lacout C."/>
<person name="Garcon L."/>
<person name="Raslova H."/>
<person name="Berger R."/>
<person name="Bennaceur-Griscelli A."/>
<person name="Villeval J.L."/>
<person name="Constantinescu S.N."/>
<person name="Casadevall N."/>
<person name="Vainchenker W."/>
</authorList>
<dbReference type="PubMed" id="15793561"/>
<dbReference type="DOI" id="10.1038/nature03546"/>
</citation>
<scope>VARIANT PV PHE-617</scope>
<scope>CHARACTERIZATION OF VARIANT PV PHE-617</scope>
</reference>
<reference key="24">
<citation type="journal article" date="2005" name="N. Engl. J. Med." volume="352" first="1779" last="1790">
<title>A gain-of-function mutation of JAK2 in myeloproliferative disorders.</title>
<authorList>
<person name="Kralovics R."/>
<person name="Passamonti F."/>
<person name="Buser A.S."/>
<person name="Teo S.-S."/>
<person name="Tiedt R."/>
<person name="Passweg J.R."/>
<person name="Tichelli A."/>
<person name="Cazzola M."/>
<person name="Skoda R.C."/>
</authorList>
<dbReference type="PubMed" id="15858187"/>
<dbReference type="DOI" id="10.1056/NEJMoa051113"/>
</citation>
<scope>VARIANT PV PHE-617</scope>
</reference>
<reference key="25">
<citation type="journal article" date="2006" name="N. Engl. J. Med." volume="354" first="2166" last="2175">
<title>Case records of the Massachusetts General Hospital. Case 15-2006: a 46-year-old woman with sudden onset of abdominal distention.</title>
<authorList>
<person name="Chung R.T."/>
<person name="Iafrate A.J."/>
<person name="Amrein P.C."/>
<person name="Sahani D.V."/>
<person name="Misdraji J."/>
</authorList>
<dbReference type="PubMed" id="16707754"/>
<dbReference type="DOI" id="10.1056/NEJMcpc069006"/>
</citation>
<scope>ASSOCIATION OF VARIANT PHE-617 WITH SUSCEPTIBILITY BUDD-CHIARI SYNDROME</scope>
</reference>
<reference key="26">
<citation type="journal article" date="2006" name="Oncogene" volume="25" first="1434" last="1436">
<title>The JAK2 V617F mutation in de novo acute myelogenous leukemias.</title>
<authorList>
<person name="Lee J.W."/>
<person name="Kim Y.G."/>
<person name="Soung Y.H."/>
<person name="Han K.J."/>
<person name="Kim S.Y."/>
<person name="Rhim H.S."/>
<person name="Min W.S."/>
<person name="Nam S.W."/>
<person name="Park W.S."/>
<person name="Lee J.Y."/>
<person name="Yoo N.J."/>
<person name="Lee S.H."/>
</authorList>
<dbReference type="PubMed" id="16247455"/>
<dbReference type="DOI" id="10.1038/sj.onc.1209163"/>
</citation>
<scope>VARIANTS AML ASN-607 AND PHE-617</scope>
</reference>
<reference key="27">
<citation type="journal article" date="2006" name="Proc. Natl. Acad. Sci. U.S.A." volume="103" first="6224" last="6229">
<title>The JAK2 V617F mutation occurs in hematopoietic stem cells in polycythemia vera and predisposes toward erythroid differentiation.</title>
<authorList>
<person name="Jamieson C.H.M."/>
<person name="Gotlib J."/>
<person name="Durocher J.A."/>
<person name="Chao M.P."/>
<person name="Mariappan M.R."/>
<person name="Lay M."/>
<person name="Jones C."/>
<person name="Zehnder J.L."/>
<person name="Lilleberg S.L."/>
<person name="Weissman I.L."/>
</authorList>
<dbReference type="PubMed" id="16603627"/>
<dbReference type="DOI" id="10.1073/pnas.0601462103"/>
</citation>
<scope>VARIANT PV PHE-617</scope>
</reference>
<reference key="28">
<citation type="journal article" date="2007" name="N. Engl. J. Med." volume="356" first="459" last="468">
<title>JAK2 exon 12 mutations in polycythemia vera and idiopathic erythrocytosis.</title>
<authorList>
<person name="Scott L.M."/>
<person name="Tong W."/>
<person name="Levine R.L."/>
<person name="Scott M.A."/>
<person name="Beer P.A."/>
<person name="Stratton M.R."/>
<person name="Futreal P.A."/>
<person name="Erber W.N."/>
<person name="McMullin M.F."/>
<person name="Harrison C.N."/>
<person name="Warren A.J."/>
<person name="Gilliland D.G."/>
<person name="Lodish H.F."/>
<person name="Green A.R."/>
</authorList>
<dbReference type="PubMed" id="17267906"/>
<dbReference type="DOI" id="10.1056/NEJMoa065202"/>
</citation>
<scope>VARIANTS MYELOPROLIFERATIVE DISORDER WITH ERYTHROCYTOSIS 537-PHE--LYS-539 DELINS LEU; 538-GLN-LEU-539 AND LEU-539</scope>
</reference>
<reference key="29">
<citation type="journal article" date="2007" name="Nature" volume="446" first="153" last="158">
<title>Patterns of somatic mutation in human cancer genomes.</title>
<authorList>
<person name="Greenman C."/>
<person name="Stephens P."/>
<person name="Smith R."/>
<person name="Dalgliesh G.L."/>
<person name="Hunter C."/>
<person name="Bignell G."/>
<person name="Davies H."/>
<person name="Teague J."/>
<person name="Butler A."/>
<person name="Stevens C."/>
<person name="Edkins S."/>
<person name="O'Meara S."/>
<person name="Vastrik I."/>
<person name="Schmidt E.E."/>
<person name="Avis T."/>
<person name="Barthorpe S."/>
<person name="Bhamra G."/>
<person name="Buck G."/>
<person name="Choudhury B."/>
<person name="Clements J."/>
<person name="Cole J."/>
<person name="Dicks E."/>
<person name="Forbes S."/>
<person name="Gray K."/>
<person name="Halliday K."/>
<person name="Harrison R."/>
<person name="Hills K."/>
<person name="Hinton J."/>
<person name="Jenkinson A."/>
<person name="Jones D."/>
<person name="Menzies A."/>
<person name="Mironenko T."/>
<person name="Perry J."/>
<person name="Raine K."/>
<person name="Richardson D."/>
<person name="Shepherd R."/>
<person name="Small A."/>
<person name="Tofts C."/>
<person name="Varian J."/>
<person name="Webb T."/>
<person name="West S."/>
<person name="Widaa S."/>
<person name="Yates A."/>
<person name="Cahill D.P."/>
<person name="Louis D.N."/>
<person name="Goldstraw P."/>
<person name="Nicholson A.G."/>
<person name="Brasseur F."/>
<person name="Looijenga L."/>
<person name="Weber B.L."/>
<person name="Chiew Y.-E."/>
<person name="DeFazio A."/>
<person name="Greaves M.F."/>
<person name="Green A.R."/>
<person name="Campbell P."/>
<person name="Birney E."/>
<person name="Easton D.F."/>
<person name="Chenevix-Trench G."/>
<person name="Tan M.-H."/>
<person name="Khoo S.K."/>
<person name="Teh B.T."/>
<person name="Yuen S.T."/>
<person name="Leung S.Y."/>
<person name="Wooster R."/>
<person name="Futreal P.A."/>
<person name="Stratton M.R."/>
</authorList>
<dbReference type="PubMed" id="17344846"/>
<dbReference type="DOI" id="10.1038/nature05610"/>
</citation>
<scope>VARIANTS [LARGE SCALE ANALYSIS] ASP-127; GLN-191; ARG-346; GLU-377; VAL-393 AND HIS-1063</scope>
</reference>
<reference key="30">
<citation type="journal article" date="2012" name="N. Engl. J. Med." volume="366" first="967" last="969">
<title>Germline JAK2 mutation in a family with hereditary thrombocytosis.</title>
<authorList>
<person name="Mead A.J."/>
<person name="Rugless M.J."/>
<person name="Jacobsen S.E."/>
<person name="Schuh A."/>
</authorList>
<dbReference type="PubMed" id="22397670"/>
<dbReference type="DOI" id="10.1056/NEJMc1200349"/>
</citation>
<scope>VARIANT THCYT3 ILE-617</scope>
</reference>
<comment type="function">
<text evidence="13 25 26 28">Non-receptor tyrosine kinase involved in various processes such as cell growth, development, differentiation or histone modifications. Mediates essential signaling events in both innate and adaptive immunity. In the cytoplasm, plays a pivotal role in signal transduction via its association with type I receptors such as growth hormone (GHR), prolactin (PRLR), leptin (LEPR), erythropoietin (EPOR), thrombopoietin (THPO); or type II receptors including IFN-alpha, IFN-beta, IFN-gamma and multiple interleukins. Following ligand-binding to cell surface receptors, phosphorylates specific tyrosine residues on the cytoplasmic tails of the receptor, creating docking sites for STATs proteins. Subsequently, phosphorylates the STATs proteins once they are recruited to the receptor. Phosphorylated STATs then form homodimer or heterodimers and translocate to the nucleus to activate gene transcription. For example, cell stimulation with erythropoietin (EPO) during erythropoiesis leads to JAK2 autophosphorylation, activation, and its association with erythropoietin receptor (EPOR) that becomes phosphorylated in its cytoplasmic domain. Then, STAT5 (STAT5A or STAT5B) is recruited, phosphorylated and activated by JAK2. Once activated, dimerized STAT5 translocates into the nucleus and promotes the transcription of several essential genes involved in the modulation of erythropoiesis. In addition, JAK2 mediates angiotensin-2-induced ARHGEF1 phosphorylation. Plays a role in cell cycle by phosphorylating CDKN1B. Cooperates with TEC through reciprocal phosphorylation to mediate cytokine-driven activation of FOS transcription. In the nucleus, plays a key role in chromatin by specifically mediating phosphorylation of 'Tyr-41' of histone H3 (H3Y41ph), a specific tag that promotes exclusion of CBX5 (HP1 alpha) from chromatin.</text>
</comment>
<comment type="catalytic activity">
<text evidence="10">ATP + a [protein]-L-tyrosine = ADP + a [protein]-L-tyrosine phosphate.</text>
</comment>
<comment type="enzyme regulation">
<text evidence="6 27">Regulated by autophosphorylation, can both activate or decrease activity (By similarity). Heme regulates its activity by enhancing the phosphorylation on Tyr-1007 and Tyr-1008.</text>
</comment>
<comment type="subunit">
<text evidence="6 11 12 13 17">Interacts with EPOR, LYN, SIRPA, SH2B1 and TEC (By similarity). Interacts with IL23R, SKB1 and STAM2.</text>
</comment>
<comment type="interaction">
<interactant intactId="EBI-518647"/>
<interactant intactId="EBI-1809771">
<id>P32927</id>
<label>CSF2RB</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-518647"/>
<interactant intactId="EBI-389883">
<id>P16333</id>
<label>NCK1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-518647"/>
<interactant intactId="EBI-968788">
<id>P18031</id>
<label>PTPN1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>5</experiments>
</comment>
<comment type="subcellular location">
<subcellularLocation>
<location evidence="6">Endomembrane system</location>
<topology evidence="6">Peripheral membrane protein</topology>
</subcellularLocation>
<subcellularLocation>
<location evidence="25">Cytoplasm</location>
</subcellularLocation>
<subcellularLocation>
<location evidence="25">Nucleus</location>
</subcellularLocation>
</comment>
<comment type="tissue specificity">
<text evidence="20">Ubiquitously expressed throughout most tissues.</text>
</comment>
<comment type="domain">
<text evidence="6">Possesses 2 protein kinase domains. The second one probably contains the catalytic domain, while the presence of slight differences suggest a different role for protein kinase 1 (By similarity).</text>
</comment>
<comment type="PTM">
<text evidence="6">Autophosphorylated, leading to regulate its activity. Leptin promotes phosphorylation on tyrosine residues, including phosphorylation on Tyr-813. Autophosphorylation on Tyr-119 in response to EPO down-regulates its kinase activity. Autophosphorylation on Tyr-868, Tyr-966 and Tyr-972 in response to growth hormone (GH) are required for maximal kinase activity. Also phosphorylated by TEC (By similarity).</text>
</comment>
<comment type="disease">
<text>Chromosomal aberrations involving JAK2 are found in both chronic and acute forms of eosinophilic, lymphoblastic and myeloid leukemia. Translocation t(8;9)(p22;p24) with PCM1 links the protein kinase domain of JAK2 to the major portion of PCM1. Translocation t(9;12)(p24;p13) with ETV6.</text>
</comment>
<comment type="disease" evidence="22">
<disease id="DI-01300">
<name>Budd-Chiari syndrome</name>
<acronym>BDCHS</acronym>
<description>A syndrome caused by obstruction of hepatic venous outflow involving either the hepatic veins or the terminal segment of the inferior vena cava. Obstructions are generally caused by thrombosis and lead to hepatic congestion and ischemic necrosis. Clinical manifestations observed in the majority of patients include hepatomegaly, right upper quadrant pain and abdominal ascites. Budd-Chiari syndrome is associated with a combination of disease states including primary myeloproliferative syndromes and thrombophilia due to factor V Leiden, protein C deficiency and antithrombin III deficiency. Budd-Chiari syndrome is a rare but typical complication in patients with polycythemia vera.</description>
<dbReference type="MIM" id="600880"/>
</disease>
<text>Disease susceptibility is associated with variations affecting the gene represented in this entry.</text>
</comment>
<comment type="disease" evidence="14 15 16 21">
<disease id="DI-02712">
<name>Polycythemia vera</name>
<acronym>PV</acronym>
<description>A myeloproliferative disorder characterized by abnormal proliferation of all hematopoietic bone marrow elements, erythroid hyperplasia, an absolute increase in total blood volume, but also by myeloid leukocytosis, thrombocytosis and splenomegaly.</description>
<dbReference type="MIM" id="263300"/>
</disease>
<text>The disease is caused by mutations affecting the gene represented in this entry.</text>
</comment>
<comment type="disease" evidence="19 29">
<disease id="DI-03402">
<name>Thrombocythemia 3</name>
<acronym>THCYT3</acronym>
<description>A myeloproliferative disorder characterized by excessive platelet production, resulting in increased numbers of circulating platelets. It can be associated with spontaneous hemorrhages and thrombotic episodes.</description>
<dbReference type="MIM" id="614521"/>
</disease>
<text>The disease may be caused by mutations affecting the gene represented in this entry.</text>
</comment>
<comment type="disease">
<disease id="DI-02746">
<name>Myelofibrosis</name>
<acronym>MYELOF</acronym>
<description>A disorder characterized by replacement of the bone marrow by fibrous tissue, occurring in association with a myeloproliferative disorder. Clinical manifestations may include anemia, pallor, splenomegaly, hypermetabolic state, petechiae, ecchymosis, bleeding, lymphadenopathy, hepatomegaly, portal hypertension.</description>
<dbReference type="MIM" id="254450"/>
</disease>
<text>The disease is caused by mutations affecting the gene represented in this entry.</text>
</comment>
<comment type="disease" evidence="18">
<disease id="DI-01171">
<name>Leukemia, acute myelogenous</name>
<acronym>AML</acronym>
<description>A subtype of acute leukemia, a cancer of the white blood cells. AML is a malignant disease of bone marrow characterized by maturational arrest of hematopoietic precursors at an early stage of development. Clonal expansion of myeloid blasts occurs in bone marrow, blood, and other tissue. Myelogenous leukemias develop from changes in cells that normally produce neutrophils, basophils, eosinophils and monocytes.</description>
<dbReference type="MIM" id="601626"/>
</disease>
<text>The disease is caused by mutations affecting the gene represented in this entry.</text>
</comment>
<comment type="similarity">
<text evidence="8">Belongs to the protein kinase superfamily. Tyr protein kinase family. JAK subfamily.</text>
</comment>
<comment type="similarity">
<text evidence="7">Contains 1 FERM domain.</text>
</comment>
<comment type="similarity">
<text evidence="8">Contains 2 protein kinase domains.</text>
</comment>
<comment type="similarity">
<text evidence="9">Contains 1 SH2 domain.</text>
</comment>
<comment type="online information" name="Atlas of Genetics and Cytogenetics in Oncology and Haematology">
<link uri="http://atlasgeneticsoncology.org/Genes/JAK98.html"/>
</comment>
<dbReference type="EC" id="2.7.10.2"/>
<dbReference type="EMBL" id="AF058925">
<property type="protein sequence ID" value="AAC23982.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AF001362">
<property type="protein sequence ID" value="AAC23653.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AF005216">
<property type="protein sequence ID" value="AAB82092.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AL161450">
<property type="protein sequence ID" value="CAD13329.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="CCDS" id="CCDS6457.1"/>
<dbReference type="PIR" id="JW0091">
<property type="entry name" value="JW0091"/>
</dbReference>
<dbReference type="RefSeq" id="NP_004963.1">
<property type="nucleotide sequence ID" value="NM_004972.3"/>
</dbReference>
<dbReference type="RefSeq" id="XP_005251512.1">
<property type="nucleotide sequence ID" value="XM_005251455.2"/>
</dbReference>
<dbReference type="UniGene" id="Hs.656213"/>
<dbReference type="PDB" id="2B7A">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.00"/>
<property type="chains" value="A/B=840-1132"/>
</dbReference>
<dbReference type="PDB" id="2W1I">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.60"/>
<property type="chains" value="A/B=835-1132"/>
</dbReference>
<dbReference type="PDB" id="2XA4">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.04"/>
<property type="chains" value="A/B=835-1132"/>
</dbReference>
<dbReference type="PDB" id="3E62">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.92"/>
<property type="chains" value="A=839-1131"/>
</dbReference>
<dbReference type="PDB" id="3E63">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.90"/>
<property type="chains" value="A=839-1131"/>
</dbReference>
<dbReference type="PDB" id="3E64">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.80"/>
<property type="chains" value="A=839-1131"/>
</dbReference>
<dbReference type="PDB" id="3FUP">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.40"/>
<property type="chains" value="A/B=840-1132"/>
</dbReference>
<dbReference type="PDB" id="3IO7">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.60"/>
<property type="chains" value="A=842-1132"/>
</dbReference>
<dbReference type="PDB" id="3IOK">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.10"/>
<property type="chains" value="A=842-1132"/>
</dbReference>
<dbReference type="PDB" id="3JY9">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.10"/>
<property type="chains" value="A=842-1130"/>
</dbReference>
<dbReference type="PDB" id="3KCK">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.20"/>
<property type="chains" value="A=842-1132"/>
</dbReference>
<dbReference type="PDB" id="3KRR">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.80"/>
<property type="chains" value="A=840-1132"/>
</dbReference>
<dbReference type="PDB" id="3LPB">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.00"/>
<property type="chains" value="A/B=840-1132"/>
</dbReference>
<dbReference type="PDB" id="3Q32">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.50"/>
<property type="chains" value="A/B=839-1132"/>
</dbReference>
<dbReference type="PDB" id="3RVG">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.50"/>
<property type="chains" value="A=835-1132"/>
</dbReference>
<dbReference type="PDB" id="3TJC">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.40"/>
<property type="chains" value="A/B=837-1132"/>
</dbReference>
<dbReference type="PDB" id="3TJD">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.90"/>
<property type="chains" value="A/B=837-1132"/>
</dbReference>
<dbReference type="PDB" id="3UGC">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.34"/>
<property type="chains" value="A=840-1132"/>
</dbReference>
<dbReference type="PDB" id="3ZMM">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.51"/>
<property type="chains" value="A/B=835-1132"/>
</dbReference>
<dbReference type="PDB" id="4AQC">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.90"/>
<property type="chains" value="A/B=835-1132"/>
</dbReference>
<dbReference type="PDB" id="4BBE">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.90"/>
<property type="chains" value="A/B/C/D=839-1132"/>
</dbReference>
<dbReference type="PDB" id="4BBF">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.00"/>
<property type="chains" value="A/B/C/D=839-1132"/>
</dbReference>
<dbReference type="PDB" id="4C61">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.45"/>
<property type="chains" value="A/B=835-1132"/>
</dbReference>
<dbReference type="PDB" id="4C62">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.75"/>
<property type="chains" value="A/B=835-1132"/>
</dbReference>
<dbReference type="PDB" id="4D0W">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.77"/>
<property type="chains" value="A=835-1132"/>
</dbReference>
<dbReference type="PDB" id="4D0X">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.82"/>
<property type="chains" value="A=835-1132"/>
</dbReference>
<dbReference type="PDB" id="4D1S">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.66"/>
<property type="chains" value="A=835-1132"/>
</dbReference>
<dbReference type="PDB" id="4E4M">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.25"/>
<property type="chains" value="A/B/D/E=833-1132"/>
</dbReference>
<dbReference type="PDB" id="4E6D">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.22"/>
<property type="chains" value="A/B=835-1132"/>
</dbReference>
<dbReference type="PDB" id="4E6Q">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.95"/>
<property type="chains" value="A/B=835-1132"/>
</dbReference>
<dbReference type="PDB" id="4F08">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.82"/>
<property type="chains" value="A/B=833-1132"/>
</dbReference>
<dbReference type="PDB" id="4F09">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.40"/>
<property type="chains" value="A=833-1132"/>
</dbReference>
<dbReference type="PDB" id="4FVP">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.01"/>
<property type="chains" value="A=536-812"/>
</dbReference>
<dbReference type="PDB" id="4FVQ">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.75"/>
<property type="chains" value="A=536-812"/>
</dbReference>
<dbReference type="PDB" id="4FVR">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.00"/>
<property type="chains" value="A=536-812"/>
</dbReference>
<dbReference type="PDB" id="4GFM">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.30"/>
<property type="chains" value="A=833-1132"/>
</dbReference>
<dbReference type="PDB" id="4GMY">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.40"/>
<property type="chains" value="A=833-1132"/>
</dbReference>
<dbReference type="PDB" id="4HGE">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.30"/>
<property type="chains" value="A/B=833-1132"/>
</dbReference>
<dbReference type="PDB" id="4IVA">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.50"/>
<property type="chains" value="A=833-1132"/>
</dbReference>
<dbReference type="PDB" id="4JI9">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.40"/>
<property type="chains" value="A/B=833-1132"/>
</dbReference>
<dbReference type="PDB" id="4JIA">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.85"/>
<property type="chains" value="A=833-1132"/>
</dbReference>
<dbReference type="PDBsum" id="2B7A"/>
<dbReference type="PDBsum" id="2W1I"/>
<dbReference type="PDBsum" id="2XA4"/>
<dbReference type="PDBsum" id="3E62"/>
<dbReference type="PDBsum" id="3E63"/>
<dbReference type="PDBsum" id="3E64"/>
<dbReference type="PDBsum" id="3FUP"/>
<dbReference type="PDBsum" id="3IO7"/>
<dbReference type="PDBsum" id="3IOK"/>
<dbReference type="PDBsum" id="3JY9"/>
<dbReference type="PDBsum" id="3KCK"/>
<dbReference type="PDBsum" id="3KRR"/>
<dbReference type="PDBsum" id="3LPB"/>
<dbReference type="PDBsum" id="3Q32"/>
<dbReference type="PDBsum" id="3RVG"/>
<dbReference type="PDBsum" id="3TJC"/>
<dbReference type="PDBsum" id="3TJD"/>
<dbReference type="PDBsum" id="3UGC"/>
<dbReference type="PDBsum" id="3ZMM"/>
<dbReference type="PDBsum" id="4AQC"/>
<dbReference type="PDBsum" id="4BBE"/>
<dbReference type="PDBsum" id="4BBF"/>
<dbReference type="PDBsum" id="4C61"/>
<dbReference type="PDBsum" id="4C62"/>
<dbReference type="PDBsum" id="4D0W"/>
<dbReference type="PDBsum" id="4D0X"/>
<dbReference type="PDBsum" id="4D1S"/>
<dbReference type="PDBsum" id="4E4M"/>
<dbReference type="PDBsum" id="4E6D"/>
<dbReference type="PDBsum" id="4E6Q"/>
<dbReference type="PDBsum" id="4F08"/>
<dbReference type="PDBsum" id="4F09"/>
<dbReference type="PDBsum" id="4FVP"/>
<dbReference type="PDBsum" id="4FVQ"/>
<dbReference type="PDBsum" id="4FVR"/>
<dbReference type="PDBsum" id="4GFM"/>
<dbReference type="PDBsum" id="4GMY"/>
<dbReference type="PDBsum" id="4HGE"/>
<dbReference type="PDBsum" id="4IVA"/>
<dbReference type="PDBsum" id="4JI9"/>
<dbReference type="PDBsum" id="4JIA"/>
<dbReference type="ProteinModelPortal" id="O60674"/>
<dbReference type="SMR" id="O60674">
<property type="residue range" value="39-1132"/>
</dbReference>
<dbReference type="BioGrid" id="109920">
<property type="interactions" value="90"/>
</dbReference>
<dbReference type="DIP" id="DIP-33880N"/>
<dbReference type="IntAct" id="O60674">
<property type="interactions" value="23"/>
</dbReference>
<dbReference type="MINT" id="MINT-158048"/>
<dbReference type="STRING" id="9606.ENSP00000371067"/>
<dbReference type="BindingDB" id="O60674"/>
<dbReference type="ChEMBL" id="CHEMBL2971"/>
<dbReference type="DrugBank" id="DB08877">
<property type="generic name" value="Ruxolitinib"/>
</dbReference>
<dbReference type="DrugBank" id="DB08895">
<property type="generic name" value="Tofacitinib"/>
</dbReference>
<dbReference type="GuidetoPHARMACOLOGY" id="2048"/>
<dbReference type="PhosphoSite" id="O60674"/>
<dbReference type="MaxQB" id="O60674"/>
<dbReference type="PaxDb" id="O60674"/>
<dbReference type="PRIDE" id="O60674"/>
<dbReference type="DNASU" id="3717"/>
<dbReference type="Ensembl" id="ENST00000381652">
<property type="protein sequence ID" value="ENSP00000371067"/>
<property type="gene ID" value="ENSG00000096968"/>
</dbReference>
<dbReference type="GeneID" id="3717"/>
<dbReference type="KEGG" id="hsa:3717"/>
<dbReference type="UCSC" id="uc003ziw.3">
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="CTD" id="3717"/>
<dbReference type="GeneCards" id="GC09P004985"/>
<dbReference type="HGNC" id="HGNC:6192">
<property type="gene designation" value="JAK2"/>
</dbReference>
<dbReference type="HPA" id="CAB013089"/>
<dbReference type="MIM" id="147796">
<property type="type" value="gene"/>
</dbReference>
<dbReference type="MIM" id="254450">
<property type="type" value="phenotype"/>
</dbReference>
<dbReference type="MIM" id="263300">
<property type="type" value="phenotype"/>
</dbReference>
<dbReference type="MIM" id="600880">
<property type="type" value="phenotype"/>
</dbReference>
<dbReference type="MIM" id="601626">
<property type="type" value="phenotype"/>
</dbReference>
<dbReference type="MIM" id="614521">
<property type="type" value="phenotype"/>
</dbReference>
<dbReference type="neXtProt" id="NX_O60674"/>
<dbReference type="Orphanet" id="131">
<property type="disease" value="Budd-Chiari syndrome"/>
</dbReference>
<dbReference type="Orphanet" id="3318">
<property type="disease" value="Essential thrombocythemia"/>
</dbReference>
<dbReference type="Orphanet" id="71493">
<property type="disease" value="Familial thrombocytosis"/>
</dbReference>
<dbReference type="Orphanet" id="824">
<property type="disease" value="Myelofibrosis with myeloid metaplasia"/>
</dbReference>
<dbReference type="Orphanet" id="729">
<property type="disease" value="Polycythemia vera"/>
</dbReference>
<dbReference type="PharmGKB" id="PA29989"/>
<dbReference type="eggNOG" id="COG0515"/>
<dbReference type="GeneTree" id="ENSGT00760000118799"/>
<dbReference type="HOGENOM" id="HOG000049158"/>
<dbReference type="HOVERGEN" id="HBG006195"/>
<dbReference type="InParanoid" id="O60674"/>
<dbReference type="KO" id="K04447"/>
<dbReference type="OMA" id="CHGPISM"/>
<dbReference type="OrthoDB" id="EOG7BW0HM"/>
<dbReference type="PhylomeDB" id="O60674"/>
<dbReference type="TreeFam" id="TF327041"/>
<dbReference type="BRENDA" id="2.7.10.2">
<property type="organism ID" value="2681"/>
</dbReference>
<dbReference type="Reactome" id="REACT_111040">
<property type="pathway name" value="Signaling by SCF-KIT"/>
</dbReference>
<dbReference type="Reactome" id="REACT_111133">
<property type="pathway name" value="Growth hormone receptor signaling"/>
</dbReference>
<dbReference type="Reactome" id="REACT_115697">
<property type="pathway name" value="Prolactin receptor signaling"/>
</dbReference>
<dbReference type="Reactome" id="REACT_1183">
<property type="pathway name" value="ERK2 activation"/>
</dbReference>
<dbReference type="Reactome" id="REACT_1391">
<property type="pathway name" value="ERK1 activation"/>
</dbReference>
<dbReference type="Reactome" id="REACT_169118">
<property type="pathway name" value="Signaling by Leptin"/>
</dbReference>
<dbReference type="Reactome" id="REACT_1695">
<property type="pathway name" value="GPVI-mediated activation cascade"/>
</dbReference>
<dbReference type="Reactome" id="REACT_19290">
<property type="pathway name" value="G beta:gamma signalling through PI3Kgamma"/>
</dbReference>
<dbReference type="Reactome" id="REACT_228108">
<property type="pathway name" value="RMTs methylate histone arginines"/>
</dbReference>
<dbReference type="Reactome" id="REACT_23837">
<property type="pathway name" value="Interleukin-3, 5 and GM-CSF signaling"/>
</dbReference>
<dbReference type="Reactome" id="REACT_23891">
<property type="pathway name" value="Interleukin receptor SHC signaling"/>
</dbReference>
<dbReference type="Reactome" id="REACT_24970">
<property type="pathway name" value="Factors involved in megakaryocyte development and platelet production"/>
</dbReference>
<dbReference type="Reactome" id="REACT_24980">
<property type="pathway name" value="Regulation of IFNG signaling"/>
</dbReference>
<dbReference type="Reactome" id="REACT_25078">
<property type="pathway name" value="Interferon gamma signaling"/>
</dbReference>
<dbReference type="Reactome" id="REACT_27307">
<property type="pathway name" value="Interleukin-6 signaling"/>
</dbReference>
<dbReference type="SignaLink" id="O60674"/>
<dbReference type="ChiTaRS" id="JAK2">
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="EvolutionaryTrace" id="O60674"/>
<dbReference type="GeneWiki" id="Janus_kinase_2"/>
<dbReference type="GenomeRNAi" id="3717"/>
<dbReference type="NextBio" id="14567"/>
<dbReference type="PRO" id="PR:O60674"/>
<dbReference type="Proteomes" id="UP000005640">
<property type="component" value="Chromosome 9"/>
</dbReference>
<dbReference type="Bgee" id="O60674"/>
<dbReference type="CleanEx" id="HS_JAK2"/>
<dbReference type="ExpressionAtlas" id="O60674">
<property type="expression patterns" value="baseline and differential"/>
</dbReference>
<dbReference type="Genevestigator" id="O60674"/>
<dbReference type="GO" id="GO:0005901">
<property type="term" value="C:caveola"/>
<property type="evidence" value="ISS:BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0005737">
<property type="term" value="C:cytoplasm"/>
<property type="evidence" value="IDA:BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0005856">
<property type="term" value="C:cytoskeleton"/>
<property type="evidence" value="IEA:InterPro"/>
</dbReference>
<dbReference type="GO" id="GO:0005829">
<property type="term" value="C:cytosol"/>
<property type="evidence" value="TAS:Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0031904">
<property type="term" value="C:endosome lumen"/>
<property type="evidence" value="TAS:Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0045121">
<property type="term" value="C:membrane raft"/>
<property type="evidence" value="ISS:BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0016363">
<property type="term" value="C:nuclear matrix"/>
<property type="evidence" value="IEA:Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0005634">
<property type="term" value="C:nucleus"/>
<property type="evidence" value="IDA:UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005524">
<property type="term" value="F:ATP binding"/>
<property type="evidence" value="IEA:UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0005131">
<property type="term" value="F:growth hormone receptor binding"/>
<property type="evidence" value="ISS:BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0020037">
<property type="term" value="F:heme binding"/>
<property type="evidence" value="IDA:UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0042393">
<property type="term" value="F:histone binding"/>
<property type="evidence" value="IDA:UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0035401">
<property type="term" value="F:histone kinase activity (H3-Y41 specific)"/>
<property type="evidence" value="IDA:UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005143">
<property type="term" value="F:interleukin-12 receptor binding"/>
<property type="evidence" value="ISS:BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0004715">
<property type="term" value="F:non-membrane spanning protein tyrosine kinase activity"/>
<property type="evidence" value="IEA:UniProtKB-EC"/>
</dbReference>
<dbReference type="GO" id="GO:0004672">
<property type="term" value="F:protein kinase activity"/>
<property type="evidence" value="NAS:ProtInc"/>
</dbReference>
<dbReference type="GO" id="GO:0019901">
<property type="term" value="F:protein kinase binding"/>
<property type="evidence" value="IDA:BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0004713">
<property type="term" value="F:protein tyrosine kinase activity"/>
<property type="evidence" value="ISS:UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005102">
<property type="term" value="F:receptor binding"/>
<property type="evidence" value="IPI:UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0042169">
<property type="term" value="F:SH2 domain binding"/>
<property type="evidence" value="IPI:UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0030041">
<property type="term" value="P:actin filament polymerization"/>
<property type="evidence" value="NAS:BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0006919">
<property type="term" value="P:activation of cysteine-type endopeptidase activity involved in apoptotic process"/>
<property type="evidence" value="ISS:BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0097296">
<property type="term" value="P:activation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway"/>
<property type="evidence" value="ISS:BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0042977">
<property type="term" value="P:activation of JAK2 kinase activity"/>
<property type="evidence" value="ISS:UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0000186">
<property type="term" value="P:activation of MAPKK activity"/>
<property type="evidence" value="IEA:Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0006915">
<property type="term" value="P:apoptotic process"/>
<property type="evidence" value="ISS:BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0031103">
<property type="term" value="P:axon regeneration"/>
<property type="evidence" value="IEA:Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0007596">
<property type="term" value="P:blood coagulation"/>
<property type="evidence" value="TAS:Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0030154">
<property type="term" value="P:cell differentiation"/>
<property type="evidence" value="ISS:BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0006928">
<property type="term" value="P:cellular component movement"/>
<property type="evidence" value="TAS:ProtInc"/>
</dbReference>
<dbReference type="GO" id="GO:0019221">
<property type="term" value="P:cytokine-mediated signaling pathway"/>
<property type="evidence" value="ISS:UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0007167">
<property type="term" value="P:enzyme linked receptor protein signaling pathway"/>
<property type="evidence" value="ISS:BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0030218">
<property type="term" value="P:erythrocyte differentiation"/>
<property type="evidence" value="ISS:UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0097191">
<property type="term" value="P:extrinsic apoptotic signaling pathway"/>
<property type="evidence" value="ISS:BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0007186">
<property type="term" value="P:G-protein coupled receptor signaling pathway"/>
<property type="evidence" value="IEA:Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0060396">
<property type="term" value="P:growth hormone receptor signaling pathway"/>
<property type="evidence" value="IDA:BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0035409">
<property type="term" value="P:histone H3-Y41 phosphorylation"/>
<property type="evidence" value="IDA:UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0009755">
<property type="term" value="P:hormone-mediated signaling pathway"/>
<property type="evidence" value="IEA:Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0034050">
<property type="term" value="P:host programmed cell death induced by symbiont"/>
<property type="evidence" value="IEA:Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0060333">
<property type="term" value="P:interferon-gamma-mediated signaling pathway"/>
<property type="evidence" value="TAS:Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0035722">
<property type="term" value="P:interleukin-12-mediated signaling pathway"/>
<property type="evidence" value="IDA:BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0035556">
<property type="term" value="P:intracellular signal transduction"/>
<property type="evidence" value="ISS:BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0008631">
<property type="term" value="P:intrinsic apoptotic signaling pathway in response to oxidative stress"/>
<property type="evidence" value="IEA:Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0007259">
<property type="term" value="P:JAK-STAT cascade"/>
<property type="evidence" value="TAS:ProtInc"/>
</dbReference>
<dbReference type="GO" id="GO:0060397">
<property type="term" value="P:JAK-STAT cascade involved in growth hormone signaling pathway"/>
<property type="evidence" value="ISS:UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0061180">
<property type="term" value="P:mammary gland epithelium development"/>
<property type="evidence" value="ISS:BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0007498">
<property type="term" value="P:mesoderm development"/>
<property type="evidence" value="TAS:ProtInc"/>
</dbReference>
<dbReference type="GO" id="GO:0031959">
<property type="term" value="P:mineralocorticoid receptor signaling pathway"/>
<property type="evidence" value="IEA:Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0008285">
<property type="term" value="P:negative regulation of cell proliferation"/>
<property type="evidence" value="ISS:BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0022408">
<property type="term" value="P:negative regulation of cell-cell adhesion"/>
<property type="evidence" value="IEA:Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0043392">
<property type="term" value="P:negative regulation of DNA binding"/>
<property type="evidence" value="ISS:BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0045822">
<property type="term" value="P:negative regulation of heart contraction"/>
<property type="evidence" value="IEA:Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0043524">
<property type="term" value="P:negative regulation of neuron apoptotic process"/>
<property type="evidence" value="IEA:Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0018108">
<property type="term" value="P:peptidyl-tyrosine phosphorylation"/>
<property type="evidence" value="ISS:BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0048008">
<property type="term" value="P:platelet-derived growth factor receptor signaling pathway"/>
<property type="evidence" value="IEA:Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0050867">
<property type="term" value="P:positive regulation of cell activation"/>
<property type="evidence" value="IEA:Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0045597">
<property type="term" value="P:positive regulation of cell differentiation"/>
<property type="evidence" value="IEA:Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0030335">
<property type="term" value="P:positive regulation of cell migration"/>
<property type="evidence" value="IEA:Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0008284">
<property type="term" value="P:positive regulation of cell proliferation"/>
<property type="evidence" value="IEA:Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0010811">
<property type="term" value="P:positive regulation of cell-substrate adhesion"/>
<property type="evidence" value="IDA:BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0007204">
<property type="term" value="P:positive regulation of cytosolic calcium ion concentration"/>
<property type="evidence" value="IEA:Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0043388">
<property type="term" value="P:positive regulation of DNA binding"/>
<property type="evidence" value="IEA:Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0060399">
<property type="term" value="P:positive regulation of growth hormone receptor signaling pathway"/>
<property type="evidence" value="ISS:BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0050729">
<property type="term" value="P:positive regulation of inflammatory response"/>
<property type="evidence" value="IEA:Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0032024">
<property type="term" value="P:positive regulation of insulin secretion"/>
<property type="evidence" value="IEA:Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0032731">
<property type="term" value="P:positive regulation of interleukin-1 beta production"/>
<property type="evidence" value="IEA:Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0045429">
<property type="term" value="P:positive regulation of nitric oxide biosynthetic process"/>
<property type="evidence" value="IEA:Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0051770">
<property type="term" value="P:positive regulation of nitric-oxide synthase biosynthetic process"/>
<property type="evidence" value="ISS:BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0050731">
<property type="term" value="P:positive regulation of peptidyl-tyrosine phosphorylation"/>
<property type="evidence" value="ISS:BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0014068">
<property type="term" value="P:positive regulation of phosphatidylinositol 3-kinase signaling"/>
<property type="evidence" value="ISS:BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0032516">
<property type="term" value="P:positive regulation of phosphoprotein phosphatase activity"/>
<property type="evidence" value="IEA:Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0033160">
<property type="term" value="P:positive regulation of protein import into nucleus, translocation"/>
<property type="evidence" value="IEA:Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0051091">
<property type="term" value="P:positive regulation of sequence-specific DNA binding transcription factor activity"/>
<property type="evidence" value="IEA:Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0032760">
<property type="term" value="P:positive regulation of tumor necrosis factor production"/>
<property type="evidence" value="ISS:BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0042517">
<property type="term" value="P:positive regulation of tyrosine phosphorylation of Stat3 protein"/>
<property type="evidence" value="ISS:UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0042523">
<property type="term" value="P:positive regulation of tyrosine phosphorylation of Stat5 protein"/>
<property type="evidence" value="ISS:BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0046777">
<property type="term" value="P:protein autophosphorylation"/>
<property type="evidence" value="ISS:UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0006468">
<property type="term" value="P:protein phosphorylation"/>
<property type="evidence" value="TAS:ProtInc"/>
</dbReference>
<dbReference type="GO" id="GO:0050727">
<property type="term" value="P:regulation of inflammatory response"/>
<property type="evidence" value="IDA:BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0060334">
<property type="term" value="P:regulation of interferon-gamma-mediated signaling pathway"/>
<property type="evidence" value="TAS:Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0046677">
<property type="term" value="P:response to antibiotic"/>
<property type="evidence" value="IDA:MGI"/>
</dbReference>
<dbReference type="GO" id="GO:0033194">
<property type="term" value="P:response to hydroperoxide"/>
<property type="evidence" value="IEA:Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0070671">
<property type="term" value="P:response to interleukin-12"/>
<property type="evidence" value="IDA:BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0032496">
<property type="term" value="P:response to lipopolysaccharide"/>
<property type="evidence" value="ISS:BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0034612">
<property type="term" value="P:response to tumor necrosis factor"/>
<property type="evidence" value="IDA:BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0007165">
<property type="term" value="P:signal transduction"/>
<property type="evidence" value="ISS:UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0007262">
<property type="term" value="P:STAT protein import into nucleus"/>
<property type="evidence" value="ISS:BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0033209">
<property type="term" value="P:tumor necrosis factor-mediated signaling pathway"/>
<property type="evidence" value="IDA:BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0007260">
<property type="term" value="P:tyrosine phosphorylation of STAT protein"/>
<property type="evidence" value="ISS:BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0042508">
<property type="term" value="P:tyrosine phosphorylation of Stat1 protein"/>
<property type="evidence" value="IEA:Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0042503">
<property type="term" value="P:tyrosine phosphorylation of Stat3 protein"/>
<property type="evidence" value="IEA:Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0042506">
<property type="term" value="P:tyrosine phosphorylation of Stat5 protein"/>
<property type="evidence" value="IEA:Ensembl"/>
</dbReference>
<dbReference type="Gene3D" id="3.30.505.10">
<property type="match status" value="1"/>
</dbReference>
<dbReference type="InterPro" id="IPR019749">
<property type="entry name" value="Band_41_domain"/>
</dbReference>
<dbReference type="InterPro" id="IPR019748">
<property type="entry name" value="FERM_central"/>
</dbReference>
<dbReference type="InterPro" id="IPR000299">
<property type="entry name" value="FERM_domain"/>
</dbReference>
<dbReference type="InterPro" id="IPR011009">
<property type="entry name" value="Kinase-like_dom"/>
</dbReference>
<dbReference type="InterPro" id="IPR000719">
<property type="entry name" value="Prot_kinase_dom"/>
</dbReference>
<dbReference type="InterPro" id="IPR017441">
<property type="entry name" value="Protein_kinase_ATP_BS"/>
</dbReference>
<dbReference type="InterPro" id="IPR001245">
<property type="entry name" value="Ser-Thr/Tyr_kinase_cat_dom"/>
</dbReference>
<dbReference type="InterPro" id="IPR000980">
<property type="entry name" value="SH2"/>
</dbReference>
<dbReference type="InterPro" id="IPR008266">
<property type="entry name" value="Tyr_kinase_AS"/>
</dbReference>
<dbReference type="InterPro" id="IPR020635">
<property type="entry name" value="Tyr_kinase_cat_dom"/>
</dbReference>
<dbReference type="InterPro" id="IPR016251">
<property type="entry name" value="Tyr_kinase_non-rcpt_Jak/Tyk2"/>
</dbReference>
<dbReference type="InterPro" id="IPR020693">
<property type="entry name" value="Tyr_kinase_non-rcpt_Jak2"/>
</dbReference>
<dbReference type="Pfam" id="PF07714">
<property type="entry name" value="Pkinase_Tyr"/>
<property type="match status" value="2"/>
</dbReference>
<dbReference type="Pfam" id="PF00017">
<property type="entry name" value="SH2"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PIRSF" id="PIRSF000636">
<property type="entry name" value="TyrPK_Jak"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PRINTS" id="PR01823">
<property type="entry name" value="JANUSKINASE"/>
</dbReference>
<dbReference type="PRINTS" id="PR01825">
<property type="entry name" value="JANUSKINASE2"/>
</dbReference>
<dbReference type="PRINTS" id="PR00109">
<property type="entry name" value="TYRKINASE"/>
</dbReference>
<dbReference type="SMART" id="SM00295">
<property type="entry name" value="B41"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SMART" id="SM00252">
<property type="entry name" value="SH2"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SMART" id="SM00219">
<property type="entry name" value="TyrKc"/>
<property type="match status" value="2"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF47031">
<property type="entry name" value="SSF47031"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF55550">
<property type="entry name" value="SSF55550"/>
<property type="match status" value="2"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF56112">
<property type="entry name" value="SSF56112"/>
<property type="match status" value="2"/>
</dbReference>
<dbReference type="PROSITE" id="PS50057">
<property type="entry name" value="FERM_3"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS00107">
<property type="entry name" value="PROTEIN_KINASE_ATP"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS50011">
<property type="entry name" value="PROTEIN_KINASE_DOM"/>
<property type="match status" value="2"/>
</dbReference>
<dbReference type="PROSITE" id="PS00109">
<property type="entry name" value="PROTEIN_KINASE_TYR"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS50001">
<property type="entry name" value="SH2"/>
<property type="match status" value="1"/>
</dbReference>
<proteinExistence type="evidence at protein level"/>
<keyword id="KW-0002">3D-structure</keyword>
<keyword id="KW-1064">Adaptive immunity</keyword>
<keyword id="KW-0067">ATP-binding</keyword>
<keyword id="KW-0156">Chromatin regulator</keyword>
<keyword id="KW-0160">Chromosomal rearrangement</keyword>
<keyword id="KW-0181">Complete proteome</keyword>
<keyword id="KW-0963">Cytoplasm</keyword>
<keyword id="KW-0225">Disease mutation</keyword>
<keyword id="KW-0391">Immunity</keyword>
<keyword id="KW-0399">Innate immunity</keyword>
<keyword id="KW-0418">Kinase</keyword>
<keyword id="KW-0472">Membrane</keyword>
<keyword id="KW-0547">Nucleotide-binding</keyword>
<keyword id="KW-0539">Nucleus</keyword>
<keyword id="KW-0597">Phosphoprotein</keyword>
<keyword id="KW-0621">Polymorphism</keyword>
<keyword id="KW-0656">Proto-oncogene</keyword>
<keyword id="KW-1185">Reference proteome</keyword>
<keyword id="KW-0677">Repeat</keyword>
<keyword id="KW-0727">SH2 domain</keyword>
<keyword id="KW-0808">Transferase</keyword>
<keyword id="KW-0829">Tyrosine-protein kinase</keyword>
<feature type="chain" description="Tyrosine-protein kinase JAK2" id="PRO_0000088112">
<location>
<begin position="1"/>
<end position="1132"/>
</location>
</feature>
<feature type="domain" description="FERM" evidence="7">
<location>
<begin position="37"/>
<end position="380"/>
</location>
</feature>
<feature type="domain" description="SH2; atypical" evidence="9">
<location>
<begin position="401"/>
<end position="482"/>
</location>
</feature>
<feature type="domain" description="Protein kinase 1" evidence="8">
<location>
<begin position="545"/>
<end position="809"/>
</location>
</feature>
<feature type="domain" description="Protein kinase 2" evidence="8">
<location>
<begin position="849"/>
<end position="1124"/>
</location>
</feature>
<feature type="nucleotide phosphate-binding region" description="ATP" evidence="8">
<location>
<begin position="855"/>
<end position="863"/>
</location>
</feature>
<feature type="region of interest" description="Interaction with cytokine/interferon/growth hormone receptors" evidence="6">
<location>
<begin position="1"/>
<end position="239"/>
</location>
</feature>
<feature type="active site" description="Proton acceptor" evidence="8 10">
<location>
<position position="976"/>
</location>
</feature>
<feature type="binding site" description="ATP" evidence="8">
<location>
<position position="882"/>
</location>
</feature>
<feature type="site" description="Breakpoint for translocation to form PCM1-JAK2 fusion protein">
<location>
<begin position="352"/>
<end position="353"/>
</location>
</feature>
<feature type="site" description="Breakpoint for translocation to form PCM1-JAK2 fusion protein">
<location>
<begin position="442"/>
<end position="443"/>
</location>
</feature>
<feature type="site" description="Breakpoint for translocation to form PCM1-JAK2 fusion protein">
<location>
<begin position="450"/>
<end position="451"/>
</location>
</feature>
<feature type="site" description="Breakpoint for translocation to form PCM1-JAK2 fusion protein">
<location>
<begin position="504"/>
<end position="505"/>
</location>
</feature>
<feature type="site" description="Breakpoint for translocation to form PCM1-JAK2 fusion protein">
<location>
<begin position="710"/>
<end position="711"/>
</location>
</feature>
<feature type="modified residue" description="Phosphotyrosine; by autocatalysis" evidence="6">
<location>
<position position="119"/>
</location>
</feature>
<feature type="modified residue" description="Phosphotyrosine" evidence="6">
<location>
<position position="372"/>
</location>
</feature>
<feature type="modified residue" description="Phosphotyrosine" evidence="6">
<location>
<position position="373"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="6">
<location>
<position position="523"/>
</location>
</feature>
<feature type="modified residue" description="Phosphotyrosine" evidence="6">
<location>
<position position="813"/>
</location>
</feature>
<feature type="modified residue" description="Phosphotyrosine; by autocatalysis" evidence="6">
<location>
<position position="868"/>
</location>
</feature>
<feature type="modified residue" description="Phosphotyrosine; by autocatalysis" evidence="6">
<location>
<position position="966"/>
</location>
</feature>
<feature type="modified residue" description="Phosphotyrosine; by autocatalysis" evidence="6">
<location>
<position position="972"/>
</location>
</feature>
<feature type="modified residue" description="Phosphotyrosine; by autocatalysis" evidence="17">
<location>
<position position="1007"/>
</location>
</feature>
<feature type="modified residue" description="Phosphotyrosine; by autocatalysis" evidence="31">
<location>
<position position="1008"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs56118985." id="VAR_041716" evidence="24">
<original>G</original>
<variation>D</variation>
<location>
<position position="127"/>
</location>
</feature>
<feature type="sequence variant" description="In an ovarian serous carcinoma sample; somatic mutation." id="VAR_041717" evidence="24">
<original>K</original>
<variation>Q</variation>
<location>
<position position="191"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs55667734." id="VAR_041718" evidence="24">
<original>K</original>
<variation>R</variation>
<location>
<position position="346"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs55953208." id="VAR_041719" evidence="24">
<original>A</original>
<variation>E</variation>
<location>
<position position="377"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs2230723." id="VAR_041720" evidence="24">
<original>L</original>
<variation>V</variation>
<location>
<position position="393"/>
</location>
</feature>
<feature type="sequence variant" description="In myeloproliferative disorder with erythrocytosis." id="VAR_032693" evidence="23">
<original>FHK</original>
<variation>L</variation>
<location>
<begin position="537"/>
<end position="539"/>
</location>
</feature>
<feature type="sequence variant" description="In myeloproliferative disorder with erythrocytosis." id="VAR_032694">
<original>HK</original>
<variation>QL</variation>
<location>
<begin position="538"/>
<end position="539"/>
</location>
</feature>
<feature type="sequence variant" description="In myeloproliferative disorder with erythrocytosis; requires 2 nucleotide substitutions." id="VAR_032695" evidence="23">
<original>K</original>
<variation>L</variation>
<location>
<position position="539"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs17490221." id="VAR_043129">
<original>D</original>
<variation>E</variation>
<location>
<position position="584"/>
</location>
</feature>
<feature type="sequence variant" description="In AML." id="VAR_032696" evidence="18">
<original>K</original>
<variation>N</variation>
<location>
<position position="607"/>
</location>
</feature>
<feature type="sequence variant" description="In PV, THCYT3 and AML; associated with susceptibility to Budd-Chiari syndrome; somatic mutation in a high percentage of patients with essential thrombocythemia or myelofibrosis; leads to constitutive tyrosine phosphorylation activity that promotes cytokine hypersensitivity." id="VAR_032697" evidence="14 15 16 18 19 21">
<original>V</original>
<variation>F</variation>
<location>
<position position="617"/>
</location>
</feature>
<feature type="sequence variant" description="In THCYT3." id="VAR_067534" evidence="29">
<original>V</original>
<variation>I</variation>
<location>
<position position="617"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs41316003." id="VAR_041721" evidence="24">
<original>R</original>
<variation>H</variation>
<location>
<position position="1063"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 1; AAC23982." ref="1" evidence="30">
<original>P</original>
<variation>S</variation>
<location>
<position position="321"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 2; AAC23653." ref="2" evidence="30">
<original>I</original>
<variation>V</variation>
<location>
<position position="1126"/>
</location>
</feature>
<feature type="helix" evidence="4">
<location>
<begin position="542"/>
<end position="544"/>
</location>
</feature>
<feature type="strand" evidence="4">
<location>
<begin position="545"/>
<end position="554"/>
</location>
</feature>
<feature type="strand" evidence="4">
<location>
<begin position="557"/>
<end position="567"/>
</location>
</feature>
<feature type="helix" evidence="4">
<location>
<begin position="569"/>
<end position="571"/>
</location>
</feature>
<feature type="strand" evidence="4">
<location>
<begin position="573"/>
<end position="583"/>
</location>
</feature>
<feature type="helix" evidence="4">
<location>
<begin position="585"/>
<end position="590"/>
</location>
</feature>
<feature type="helix" evidence="4">
<location>
<begin position="591"/>
<end position="602"/>
</location>
</feature>
<feature type="strand" evidence="4">
<location>
<begin position="612"/>
<end position="616"/>
</location>
</feature>
<feature type="strand" evidence="4">
<location>
<begin position="623"/>
<end position="627"/>
</location>
</feature>
<feature type="helix" evidence="4">
<location>
<begin position="634"/>
<end position="640"/>
</location>
</feature>
<feature type="helix" evidence="4">
<location>
<begin position="642"/>
<end position="644"/>
</location>
</feature>
<feature type="helix" evidence="4">
<location>
<begin position="647"/>
<end position="666"/>
</location>
</feature>
<feature type="helix" evidence="4">
<location>
<begin position="676"/>
<end position="678"/>
</location>
</feature>
<feature type="strand" evidence="4">
<location>
<begin position="679"/>
<end position="683"/>
</location>
</feature>
<feature type="helix" evidence="4">
<location>
<begin position="687"/>
<end position="689"/>
</location>
</feature>
<feature type="strand" evidence="4">
<location>
<begin position="694"/>
<end position="697"/>
</location>
</feature>
<feature type="turn" evidence="4">
<location>
<begin position="704"/>
<end position="706"/>
</location>
</feature>
<feature type="helix" evidence="4">
<location>
<begin position="709"/>
<end position="714"/>
</location>
</feature>
<feature type="turn" evidence="4">
<location>
<begin position="715"/>
<end position="718"/>
</location>
</feature>
<feature type="helix" evidence="4">
<location>
<begin position="721"/>
<end position="725"/>
</location>
</feature>
<feature type="helix" evidence="4">
<location>
<begin position="727"/>
<end position="729"/>
</location>
</feature>
<feature type="helix" evidence="4">
<location>
<begin position="732"/>
<end position="747"/>
</location>
</feature>
<feature type="turn" evidence="4">
<location>
<begin position="748"/>
<end position="750"/>
</location>
</feature>
<feature type="turn" evidence="4">
<location>
<begin position="753"/>
<end position="756"/>
</location>
</feature>
<feature type="helix" evidence="4">
<location>
<begin position="759"/>
<end position="767"/>
</location>
</feature>
<feature type="helix" evidence="4">
<location>
<begin position="781"/>
<end position="787"/>
</location>
</feature>
<feature type="helix" evidence="4">
<location>
<begin position="792"/>
<end position="794"/>
</location>
</feature>
<feature type="helix" evidence="4">
<location>
<begin position="798"/>
<end position="806"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="836"/>
<end position="838"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="846"/>
<end position="848"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="849"/>
<end position="857"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="859"/>
<end position="868"/>
</location>
</feature>
<feature type="strand" evidence="5">
<location>
<begin position="872"/>
<end position="874"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="877"/>
<end position="885"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="889"/>
<end position="903"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="913"/>
<end position="917"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="919"/>
<end position="922"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="926"/>
<end position="930"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="937"/>
<end position="943"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="945"/>
<end position="947"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="950"/>
<end position="969"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="979"/>
<end position="981"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="982"/>
<end position="986"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="989"/>
<end position="992"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="995"/>
<end position="997"/>
</location>
</feature>
<feature type="strand" evidence="5">
<location>
<begin position="1006"/>
<end position="1009"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="1017"/>
<end position="1020"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="1023"/>
<end position="1028"/>
</location>
</feature>
<feature type="strand" evidence="5">
<location>
<begin position="1030"/>
<end position="1032"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="1033"/>
<end position="1049"/>
</location>
</feature>
<feature type="helix" evidence="5">
<location>
<begin position="1053"/>
<end position="1055"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="1057"/>
<end position="1065"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="1072"/>
<end position="1083"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="1096"/>
<end position="1105"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="1110"/>
<end position="1112"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="1116"/>
<end position="1128"/>
</location>
</feature>
<evidence key="1" type="ECO:0000244">
<source>
<dbReference type="PDB" id="3UGC"/>
</source>
</evidence>
<evidence key="2" type="ECO:0000244">
<source>
<dbReference type="PDB" id="4D1S"/>
</source>
</evidence>
<evidence key="3" type="ECO:0000244">
<source>
<dbReference type="PDB" id="4E4M"/>
</source>
</evidence>
<evidence key="4" type="ECO:0000244">
<source>
<dbReference type="PDB" id="4FVQ"/>
</source>
</evidence>
<evidence key="5" type="ECO:0000244">
<source>
<dbReference type="PDB" id="4IVA"/>
</source>
</evidence>
<evidence key="6" type="ECO:0000250"/>
<evidence key="7" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU00084"/>
</source>
</evidence>
<evidence key="8" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU00159"/>
</source>
</evidence>
<evidence key="9" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU00191"/>
</source>
</evidence>
<evidence key="10" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU10028"/>
</source>
</evidence>
<evidence key="11" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10531356"/>
</source>
</evidence>
<evidence key="12" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10899310"/>
</source>
</evidence>
<evidence key="13" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12023369"/>
</source>
</evidence>
<evidence key="14" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15781101"/>
</source>
</evidence>
<evidence key="15" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15793561"/>
</source>
</evidence>
<evidence key="16" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15858187"/>
</source>
</evidence>
<evidence key="17" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16174768"/>
</source>
</evidence>
<evidence key="18" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16247455"/>
</source>
</evidence>
<evidence key="19" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16325696"/>
</source>
</evidence>
<evidence key="20" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16424865"/>
</source>
</evidence>
<evidence key="21" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16603627"/>
</source>
</evidence>
<evidence key="22" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16707754"/>
</source>
</evidence>
<evidence key="23" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17267906"/>
</source>
</evidence>
<evidence key="24" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17344846"/>
</source>
</evidence>
<evidence key="25" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19783980"/>
</source>
</evidence>
<evidence key="26" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="20098430"/>
</source>
</evidence>
<evidence key="27" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="21036157"/>
</source>
</evidence>
<evidence key="28" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="21423214"/>
</source>
</evidence>
<evidence key="29" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="22397670"/>
</source>
</evidence>
<evidence key="30" type="ECO:0000305"/>
<evidence key="31" type="ECO:0000305">
<source>
<dbReference type="PubMed" id="16174768"/>
</source>
</evidence>
<sequence length="1132" mass="130674" checksum="C30669EF1A7DA80C" modified="2001-01-24" version="2">
MGMACLTMTEMEGTSTSSIYQNGDISGNANSMKQIDPVLQVYLYHSLGKSEADYLTFPSG
EYVAEEICIAASKACGITPVYHNMFALMSETERIWYPPNHVFHIDESTRHNVLYRIRFYF
PRWYCSGSNRAYRHGISRGAEAPLLDDFVMSYLFAQWRHDFVHGWIKVPVTHETQEECLG
MAVLDMMRIAKENDQTPLAIYNSISYKTFLPKCIRAKIQDYHILTRKRIRYRFRRFIQQF
SQCKATARNLKLKYLINLETLQSAFYTEKFEVKEPGSGPSGEEIFATIIITGNGGIQWSR
GKHKESETLTEQDLQLYCDFPNIIDVSIKQANQEGSNESRVVTIHKQDGKNLEIELSSLR
EALSFVSLIDGYYRLTADAHHYLCKEVAPPAVLENIQSNCHGPISMDFAISKLKKAGNQT
GLYVLRCSPKDFNKYFLTFAVERENVIEYKHCLITKNENEEYNLSGTKKNFSSLKDLLNC
YQMETVRSDNIIFQFTKCCPPKPKDKSNLLVFRTNGVSDVPTSPTLQRPTHMNQMVFHKI
RNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASM
MSKLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAWA
MHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDILQERIPWVP
PECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFYEDRHQLPAPKWAEL
ANLINNCMDYEPDFRPSFRAIIRDLNSLFTPDYELLTENDMLPNMRIGALGFSGAFEDRD
PTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIE
ILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQI
CKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFW
YAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIE
LLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDNMAG
</sequence>
</entry>
<copyright>
Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
Distributed under the Creative Commons Attribution-NoDerivs License
</copyright>
</uniprot>